MedTrace Logo

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours

NCT04717674 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-10-03

No results posted yet for this study

Summary

The study will be a phase 2, open-label study in patients with solid tumours to explore the relationship between short-chain fatty acid uptake using \[18F\]FPIA PET/CT and tumour proliferation

Conditions

Interventions

DRUG

[18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid)

\[18F\]FPIA radiotracer administration

PROCEDURE

PET/CT

PET/CT scan

Sponsors & Collaborators

  • Cancer Research UK

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • National Cancer Imaging Translational Accelerator

    collaborator UNKNOWN

  • University College, London

    lead OTHER

Principal Investigators

  • Tara Barwick · University College, London

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-07
Primary Completion
2024-08-31
Completion
2024-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717674 on ClinicalTrials.gov